Sarah Zielsdorf, MD, MS - Patient on Fire: Hashimoto's (2017 Conference) (LDN, low dose naltrexone)

Dr Zielsdorf is a functional medicine physician and a board certified internist at the Institute for personal development. Sarah practices in Romeoville and Morris, Illinois in the United States.

Pradeep Chopra, MD - Chronic Pain (2013 Conference) (LDN, low dose naltrexone)

Dr Chopra's Slide Presentation

Pradeep Chopra, MD - Mechanism of action of low dose naltrexone (2016 Conference) (LDN, low dose naltrexone)

Download Dr. Chopra's Mechanism of Action Presentation

Nasha Winters, ND - The Low Down on LDN (2017 Conference) (LDN, low dose naltrexone)

In this presentation Dr Winters talks about the history of Low Dose Naltrexone (LDN) and recounts its remarkable story in terms of treatment in HIV patients and the positive effects it can have on immunodeficient patients.

Leonard Weinstock, MD - Low Dose Naltrexone and Sarcoidosis Therapy (2018 Conference) (LDN, low dose naltrexone)

Dr Leonard Weinstock is from St Louis in Missouri and helps patients with GI Issues and other autoimmune conditions.

Dana Flavin, MD - Reversing Cancer with Biochemistry (2018 Conference) (LDN, low dose naltrexone)

Dr Dana Flavin shares her presentation on Reversing Cancer at the LDN 2018 Conference.

Brian Udell, MD - Autism (2016 Conference) (LDN, low dose naltrexone)

Download Dr. Udell's Autism Presentation

Dr Brian Udell has been treating patients with Autism since 1975 and opened his clinic in 2008 for developmentally delayed children. 

Akbar Khan, MD - Cancer Case Studies (2016 Conference) (LDN, low dose naltrexone)

In this presentation Dr Khan talks about many case studies involving Transitional cell carcinoma (TCC), colon cancer and Adenoid cystic carcinoma (ACC), explaining how Low Dose Naltrexone (LDN) can improve the lives of cancer patients.

Darin Ingels, ND - Lyme Disease (2017 Conference) (LDN, low dose naltrexone)

In this presentation Dr Ingels adopts a scientific approach of explaining Lyme Disease, thus the audience can thoroughly understand why specific approaches and treatments work and others do not.

It is commonly misdiagnosed or not diagnosed at all. Lyme disease testing is inadequate and false negative tests are commonplace.

Deanna Windham, DO - Psoriasis: A Novel Approach to Treatment (2017 Conference) (LDN, low dose naltrexone)

In this presentation, Dr Windham speaks about the patients in her practice and how her wealth of experience has helped her to be able to treat newer patients with greater efficacy. She also mentions the rapidly changing scientific outlook on Psoriasis, emphasising the importance of new research.